Type 2 & other diabetes

Prognostic impact of metformin in diabetic patients undergoing a percutaneous coronary intervention (PCI): protective effect is modified by procedural complexity

Cardiovasc DiabetolPublished Prospective cohort study

Main finding · 3-year MACCEsResult — go to the resultAdjusted hazard ratio 0.80 95% CI 0.70–0.92

Authors' conclusion

In this observational study, there was significant difference in the efficacy of metformin in diabetic patients undergoing complex or non-complex PCI. Metformin use was associated with improved prognosis in patients with diabetes undergoing non-complex PCI.

Study context

Population
Patients with diabetes undergoing PCI at Fuwai hospital, January 2017 to December 2018; categorized into four groups by metformin use and PCI complexity
Participants
11,585 patients
Exposure
Metformin use vs no metformin use, by PCI complexity
Outcome
MACCEs: cardiovascular death, non-fatal myocardial infarction (MI), non-fatal stroke and unplanned revascularization
Follow-up
3 years
Methodological detailssingle-centre, consecutive enrolment, multivariable adjustment
  • Single-centre
  • Consecutive enrolment
  • Multivariable adjustment

Main finding

3-year MACCEs

Adjusted hazard ratio

0.80

95% CI 0.70–0.92

Metforminvs No metformin
adjusted HR 0.80 (95% CI 0.70–0.92)

As reported in the abstract

Total major adverse cardiovascular and cerebrovascular events (MACCEs) recorded
1292

Observational data: associations, not effects.

Further findings

OutcomeAdjusted HR (95% CI)
MACCEs, non-complex PCI subgroup · 3 yearsNon-complex PCI0.65 (0.53–0.79)
MACCEs, complex PCI subgroup · 3 yearsComplex PCI1.00 (0.83–1.21)

Interaction between metformin and PCI complexity for 3-year MACCE rate

Pinteraction
0.003
Adjusted Pinteraction
0.002

Original publication

Prognostic impact of metformin in diabetic patients undergoing a percutaneous coronary intervention (PCI): protective effect is modified by procedural complexity. Cardiovasc Diabetol. Published 14 February 2026. doi:10.1186/s12933-026-03102-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.